Dyslipidemia among psychiatric patients with depression – common possible reasons and treatment implications – review
DOI:
https://doi.org/10.12775/QS.2024.15.51715Keywords
dyslipidemia, depression, physical exercises, diet, statins, inflammationAbstract
Dyslipidemia is a medical term used to describe an abnormal level of lipids (fats) in the blood. This can include elevated levels of total cholesterol, low-density lipoprotein (LDL) cholesterol, high density protein lipoprotein (HDL) cholesterol and serum triglicerides. Depression, also known as depressive disorder, is a common mental illness. It is characterized by a persistent feeling of sadness, loss of pleasure, or lack of interest in activities that are present of at least two weeks and significantly impair patient everyday functioning. Dyslipidemia and depression can co-occur due to a complex interplay of shared risk factors, such as inflammation, metabolic syndrome, medication side effects, and lifestyle changes, suggesting a bidirectional relationship where each condition might contribute to the development or exacerbation of the other.
Given these considerations, a comprehensive approach to managing dyslipidemia in psychiatric patients with depression is essential. This should include regular monitoring of lipid profiles and monitoring of anticholesterol and antidepressant drugs. Interestingly, simple lifestyle changes, such as a healthy diet and exercise, have an impact on the treatment of depression and dyslipidemia.
References
Jacobsen AP, Whelton SP, Blumenthal RS, Mcevoy JW. Dyslipidemia. In: Hypertension: A Companion to Braunwald’s Heart Disease. 2023.
Saravane D. Dyslipidemia and Mental Illness. In: Dyslipidemia - From Prevention to Treatment. 2012.
WHO. https://www.who.int/news-room/fact-sheets/detail/depression. Int Immunopharmacol. 2019;67(August 2018).
Fentie D, Yibabie S. Magnitude and associated factors of dyslipidemia among patients with severe mental illness in dire Dawa, Ethiopia: neglected public health concern. BMC Cardiovasc Disord. 2023;23(1).
Penninx BWJH, Lange SMM. Metabolic syndrome in psychiatric patients: Overview, mechanisms, and implications. Dialogues Clin Neurosci. 2018;20(1).
Wilson PWF. High-density lipoprotein, low-density lipoprotein and coronary artery disease. Am J Cardiol. 1990;66(6).
Shin JY, Suls J, Martin R. Are cholesterol and depression inversely related? A meta-analysis of the association between two cardiac risk factors. Ann Behav Med. 2008;36(1).
Bharti V, Bhardwaj A, Hood K, Elias DA, Metcalfe AWS, Kim JS. A systematic review and meta-analysis of lipid metabolomic signatures of Major Depressive Disorder. J Psychiatr Res. 2021;139.
Enko D, Brandmayr W, Halwachs-Baumann G, Schnedl WJ, Meinitzer A, Kriegshäuser G. Prospective plasma lipid profiling in individuals with and without depression. Lipids Health Dis. 2018;17(1).
Cepeda MS, Kern DM, Blacketer C, Drevets WC. Low levels of cholesterol and the cholesterol type are not associated with depression: Results of a cross-sectional NHANES study. J Clin Lipidol. 2020;14(4).
Kirkpatrick CF, Sikand G, Petersen KS, Anderson CAM, Aspry KE, Bolick JP, et al. Nutrition interventions for adults with dyslipidemia: A Clinical Perspective from the National Lipid Association. Vol. 17, Journal of Clinical Lipidology. 2023.
Herman JP, McKlveen JM, Ghosal S, Kopp B, Wulsin A, Makinson R, et al. Regulation of the hypothalamic-pituitary- adrenocortical stress response. Compr Physiol. 2016;6(2).
Lopez-Duran NL, Kovacs M, George CJ. Hypothalamic-pituitary-adrenal axis dysregulation in depressed children and adolescents: A meta-analysis. Vol. 34, Psychoneuroendocrinology. 2009.
Nandam LS, Brazel M, Zhou M, Jhaveri DJ. Cortisol and Major Depressive Disorder—Translating Findings From Humans to Animal Models and Back. Vol. 10, Frontiers in Psychiatry. 2020.
Stephens MAC, Wand G. Stress and the HPA axis: Role of glucocorticoids in alcohol dependence. Vol. 34, Alcohol Research: Current Reviews. 2012.
Yaribeygi H, Maleki M, Butler AE, Jamialahmadi T, Sahebkar A. MOLECULAR MECHANISMS LINKING STRESS AND INSULIN RESISTANCE. EXCLI J. 2022;21.
Alshak MN, M Das J. Neuroanatomy, Sympathetic Nervous System. StatPearls. 2019.
Won E, Kim Y-K. Stress, the Autonomic Nervous System, and the Immune-kynurenine Pathway in the Etiology of Depression. Curr Neuropharmacol. 2016;14(7).
Stanciu S, Rusu E, Miricescu D, Radu AC, Axinia B, Vrabie AM, et al. Links between Metabolic Syndrome and Hypertension: The Relationship with the Current Antidiabetic Drugs. Vol. 13, Metabolites. 2023.
Shao Q, Wu Y, Ji J, Xu T, Yu Q, Ma C, et al. Interaction Mechanisms Between Major Depressive Disorder and Non-alcoholic Fatty Liver Disease. Front Psychiatry. 2021;12.
Qiu W, Cai X, Zheng C, Qiu S, Ke H, Huang Y. Update on the Relationship Between Depression and Neuroendocrine Metabolism. Vol. 15, Frontiers in Neuroscience. 2021.
Lee CH, Giuliani F. The Role of Inflammation in Depression and Fatigue. Vol. 10, Frontiers in immunology. 2019.
Tangvarasittichai S, Pongthaisong S, Tangvarasittichai O. Tumor Necrosis Factor-Α, Interleukin-6, C-Reactive Protein Levels and Insulin Resistance Associated with Type 2 Diabetes in Abdominal Obesity Women. Indian J Clin Biochem. 2016;31(1).
Chen Y, Yu CY, Deng WM. The role of pro-inflammatory cytokines in lipid metabolism of metabolic diseases. Vol. 38, International Reviews of Immunology. 2019.
Maury E, Brichard SM. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Vol. 314, Molecular and Cellular Endocrinology. 2010.
Andersson CX, Gustafson B, Hammarstedt A, Hedjazifar S, Smith U. Inflamed adipose tissue, insulin resistance and vascular injury. Vol. 24, Diabetes/Metabolism Research and Reviews. 2008.
Köhler CA, Freitas TH, Maes M, de Andrade NQ, Liu CS, Fernandes BS, et al. Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta Psychiatr Scand. 2017;135(5).
Eyre HA, Air T, Pradhan A, Johnston J, Lavretsky H, Stuart MJ, et al. A meta-analysis of chemokines in major depression. Prog Neuro-Psychopharmacology Biol Psychiatry. 2016;68.
Leighton SP, Nerurkar L, Krishnadas R, Johnman C, Graham GJ, Cavanagh J. Chemokines in depression in health and in inflammatory illness: A systematic review and meta-Analysis. Vol. 23, Molecular Psychiatry. 2018.
Koo JW, Russo SJ, Ferguson D, Nestler EJ, Duman RS. Nuclear factor-κB is a critical mediator of stress-impaired neurogenesis and depressive behavior. Proc Natl Acad Sci U S A. 2010;107(6).
Chatterjee T, De D, Chowdhury S, Bhattacharyya M. Nuclear factor NF-κB1 functional promoter polymorphism and its expression conferring the risk of Type 2 diabetes-associated dyslipidemia. Mamm Genome. 2020;31(7–8).
Chen L, Chen R, Wang H, Liang F. Mechanisms Linking Inflammation to Insulin Resistance. Vol. 2015, International Journal of Endocrinology. 2015.
Colasanto M, Madigan S, Korczak DJ. Depression and inflammation among children and adolescents: A meta-analysis. Vol. 277, Journal of Affective Disorders. 2020.
Hong N, Lin Y, Ye Z, Yang C, Huang Y, Duan Q, et al. The relationship between dyslipidemia and inflammation among adults in east coast China: A cross-sectional study. Front Immunol. 2022;13.
Shi J, Fan J, Su Q, Yang Z. Cytokines and Abnormal Glucose and Lipid Metabolism. Vol. 10, Frontiers in Endocrinology. 2019.
da Silva Rosa SC, Nayak N, Caymo AM, Gordon JW. Mechanisms of muscle insulin resistance and the cross-talk with liver and adipose tissue. Vol. 8, Physiological Reports. 2020.
Sarno E, Moeser AJ, Robison AJ. Neuroimmunology of depression. In: Advances in Pharmacology. 2021.
Kim D, Chung H, Lee JE, Kim J, Hwang J, Chung Y. Immunologic aspects of dyslipidemia: A critical regulator of adaptive immunity and immune disorders. Vol. 10, Journal of Lipid and Atherosclerosis. 2021.
Ko SH, Kim HS. Menopause-associated lipid metabolic disorders and foods beneficial for postmenopausal women. Vol. 12, Nutrients. 2020.
Bizoń A, Franik G, Niepsuj J, Czwojdzińska M, Leśniewski M, Nowak A, et al. The associations between sex hormones and lipid profiles in serum of women with different phenotypes of polycystic ovary syndrome. J Clin Med. 2021;10(17).
Kundakovic M, Rocks D. Sex hormone fluctuation and increased female risk for depression and anxiety disorders: From clinical evidence to molecular mechanisms. Vol. 66, Frontiers in Neuroendocrinology. 2022.
Klop B, Elte JWF, Cabezas MC. Dyslipidemia in Obesity: Mechanisms and Potential Targets. Vol. 5, Nutrients. 2013.
Loosen PT. Hormones of the hypothalamic-pituitary-thyroid axis: A psychoneuroendocrine perspective. Pharmacopsychiatry. 1986;19(6).
Vandoolaeghe E, Maes M, Vandevyvere J, Neels H. Hypothalamic-pituitary-thyroid-axis function in treatment resistant depression. J Affect Disord. 1997;43(2).
Bauer MS, Whybrow PC, Winokur A. Rapid Cycling Bipolar Affective Disorder: I. Association with Grade I Hypothyroidism. Arch Gen Psychiatry. 1990;47(5).
Jackson IMD. The thyroid axis and depression. In: Thyroid. 1998.
Sullivan GM, Hatterer JA, Herbert J, Chen X, Roose SP, Attia E, et al. Low levels of transthyretin in the CSF of depressed patients. Am J Psychiatry. 1999;156(5).
Choi JW, Choi HS. The regulatory effects of thyroid hormone on the activity of 3-hydroxy- 3-methylglutaryl coenzyme a reductase. Endocr Res. 2000;26(1).
Lam KSL, Chan MK, Yeung RTT. High-density lipoprotein cholesterol, hepatic lipase and lipoprotein lipase activities in thyroid dysfunction – effects of treatment. QJM. 1986;59(2).
Mavromati M, Jornayvaz FR. Review hypothyroidism-associated dyslipidemia: Potential molecular mechanisms leading to NAFLD. Vol. 22, International Journal of Molecular Sciences. 2021.
Gajewska A, Strzelecki D, Gawlik-Kotelnicka O. Ghrelin as a Biomarker of “Immunometabolic Depression” and Its Connection with Dysbiosis. Vol. 15, Nutrients. 2023.
Zou X, Zhong L, Zhu C, Zhao H, Zhao F, Cui R, et al. Role of leptin in mood disorder and neurodegenerative disease. Vol. 13, Frontiers in Neuroscience. 2019.
Rojas JM, Bruinstroop E, Printz RL, Alijagic-Boers A, Foppen E, Turney MK, et al. Central nervous system neuropeptide Y regulates mediators of hepatic phospholipid remodeling and very low-density lipoprotein triglyceride secretion via sympathetic innervation. Mol Metab. 2015;4(3).
Sharma A, Ren X, Zhang H, Pandey GN. Effect of depression and suicidal behavior on neuropeptide Y (NPY) and its receptors in the adult human brain: A postmortem study. Prog Neuro-Psychopharmacology Biol Psychiatry. 2022;112.
Huang Y, Li L, Gan Y, Wang C, Jiang H, Cao S, et al. Sedentary behaviors and risk of depression: a meta-analysis of prospective studies. Vol. 10, Translational Psychiatry. 2020.
Crichton GE, Alkerwi A. Physical activity, sedentary behavior time and lipid levels in the Observation of Cardiovascular Risk Factors in Luxembourg study. Lipids Health Dis. 2015;14(1).
Guilleminault L, Williams EJ, Scott HA, Berthon BS, Jensen M, Wood LG. Diet and asthma: Is it time to adapt our message? Vol. 9, Nutrients. 2017.
Firth J, Marx W, Dash S, Carney R, Teasdale SB, Solmi M, et al. The Effects of Dietary Improvement on Symptoms of Depression and Anxiety: A Meta-Analysis of Randomized Controlled Trials. Psychosom Med. 2019;81(3).
Na W, Chung B, Sohn C. A Relationship between Dietary Patterns and Dyslipidemia in Urban-dwelling Middle-Aged Korean Men: Using Korean Genome and Epidemiology Study (KoGES). Clin Nutr Res. 2019;8(3).
Asarnow LD, Mirchandaney R. Sleep and Mood Disorders Among Youth. Vol. 30, Child and Adolescent Psychiatric Clinics of North America. 2021.
McCall WV, Blocker JN, D’Agostino R, Kimball J, Boggs N, Lasater B, et al. Treatment of insomnia in depressed insomniacs: Effects on health-related quality of life, objective and self-reported sleep, and depression. J Clin Sleep Med. 2010;6(4).
Manber R, Edinger JD, Gress JL, San Pedro-Salcedo MG, Kuo TF, Kalista T. Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia. Sleep. 2008;31(4).
Tsiptsios D, Leontidou E, Fountoulakis PN, Ouranidis A, Matziridis A, Manolis A, et al. Association between sleep insufficiency and dyslipidemia: a cross-sectional study among Greek adults in the primary care setting. Sleep Sci. 2022;15.
Kathryn Mchugh R, Weiss RD. Alcohol use disorder and depressive disorders. Alcohol Res Curr Rev. 2019;40(1).
Huang S, Li J, Shearer GC, Lichtenstein AH, Zheng X, Wu Y, et al. Longitudinal study of alcohol consumption and HDL concentrations: A community-based study. Am J Clin Nutr. 2017;105(4).
Park H, Kim K. Relationship between alcohol consumption and serum lipid levels in elderly Korean men. Arch Gerontol Geriatr. 2012;55(2).
Walker AJ, Kim Y, Borissiouk I, Rehder R, Dodd S, Morris G, et al. Statins: Neurobiological underpinnings and mechanisms in mood disorders. Vol. 128, Neuroscience and Biobehavioral Reviews. 2021.
Giorgi R De, Crescenzo F De, Pesci NR, Martens M, Howard W, Cowen PJ, et al. Statins for major depressive disorder: A systematic review and meta-analysis of randomized controlled trials. Vol. 16, PLoS ONE. 2021.
Singh D, Lippmann S. Can statins diminish depression? Prim Care Companion J Clin Psychiatry. 2018;20(1).
Tatley M, Savage R. Psychiatric adverse reactions with statins, fibrates and ezetimibe: Implications for the use of lipid-lowering agents. Vol. 30, Drug Safety. 2007.
Bao X, Liang Y, Chang H, Cai T, Feng B, Gordon K, et al. Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside. Vol. 9, Signal Transduction and Targeted Therapy. 2024.
Hasler G. Pathophysiology of depression: Do we have any solid evidence of interest to clinicians? Vol. 9, World Psychiatry. 2010.
Edinoff AN, Raveendran K, Colon MA, Thomas BH, Trettin KA, Hunt GW, et al. Selective Serotonin Reuptake Inhibitors and Associated Bleeding Risks: A Narrative and Clinical Review. Heal Psychol Res. 2022;10(4).
McIntyre RS, Park KY, Law CWY, Sultan F, Adams A, Lourenco MT, et al. The Association between Conventional Antidepressants and the Metabolic Syndrome. CNS Drugs. 2010;24(9).
Stuchtey FC, Block A, Osei F, Wippert PM. Lipid Biomarkers in Depression: Does Antidepressant Therapy Have an Impact? Healthc. 2022;10(2).
Fanelli D, Weller G, Liu H. New serotonin-norepinephrine reuptake inhibitors and their anesthetic and analgesic considerations. Vol. 13, Neurology International. 2021.
Richards-Belle A, Austin-Zimmerman I, Wang B, Zartaloudi E, Cotic M, Gracie C, et al. Associations of antidepressants and antipsychotics with lipid parameters: Do CYP2C19/CYP2D6 genes play a role? A UK population-based study. J Psychopharmacol. 2023;37(4).
Oakes TM, Katona C, Liu P, Robinson M, Raskin J, Greist JH. Safety and tolerability of duloxetine in elderly patients with major depressive disorder: A pooled analysis of two placebo-controlled studies. Int Clin Psychopharmacol. 2013;28(1).
Vos CF, Aarnoutse RE, Op de Coul MJM, Spijker J, Groothedde-Kuyvenhoven MM, Mihaescu R, et al. Tricyclic antidepressants for major depressive disorder: a comprehensive evaluation of current practice in the Netherlands. BMC Psychiatry. 2021;21(1).
Lechner K, Heel S, Uhr M, Dose T, Holsboer F, Lucae S, et al. Weight-gain independent effect of mirtazapine on fasting plasma lipids in healthy men. Naunyn Schmiedebergs Arch Pharmacol. 2023;396(9).
Recchia F, Leung CK, Chin EC, Fong DY, Montero D, Cheng CP, et al. Comparative effectiveness of exercise, antidepressants and their combination in treating non-severe depression: A systematic review and network meta-analysis of randomised controlled trials. Vol. 56, British Journal of Sports Medicine. 2022.
Yu Q, Wong KK, Lei OK, Nie J, Shi Q, Zou L, et al. Comparative Effectiveness of Multiple Exercise Interventions in the Treatment of Mental Health Disorders: A Systematic Review and Network Meta-Analysis. Vol. 8, Sports Medicine - Open. 2022.
Schuch FB, Deslandes AC, Stubbs B, Gosmann NP, Silva CTB da, Fleck MP de A. Neurobiological effects of exercise on major depressive disorder: A systematic review. Vol. 61, Neuroscience and Biobehavioral Reviews. 2016.
Archer T. Physical Exercise as an Epigenetic Factor Determining Behavioral Outcomes. Clin Exp Psychol. 2015;01(01).
Rhee EJ, Kim HC, Kim JH, Lee EY, Kim BJ, Kim EM, et al. 2018 guidelines for the management of dyslipidemia. Korean J Intern Med. 2019;34(4).
Kelley GA, Kelley KS. Aerobic exercise and HDL2-C: A meta-analysis of randomized controlled trials. Atherosclerosis. 2006;184(1).
Varady KA, St-Pierre AC, Lamarche B, Jones PJH. Effect of plant sterols and endurance training on LDL particle size and distribution in previously sedentary hypercholesterolemic adults. Eur J Clin Nutr. 2005;59(4).
Watt MJ, Heigenhauser GJF, Dyck DJ, Spriet LL. Intramuscular triacyglycerol, glycogen and acetyl group metabolism during 4 h of moderate exercise in man. J Physiol. 2002;541(3).
Ringseis R, Mooren FC, Keller J, Couturier A, Wen G, Hirche F, et al. Regular endurance exercise improves the diminished hepatic carnitine status in mice fed a high-fat diet. Mol Nutr Food Res. 2011;55(SUPPL. 2).
Steensberg A, Fischer CP, Keller C, Møller K, Pedersen BK. IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am J Physiol - Endocrinol Metab. 2003;285(2 48-2).
Starkie R, Ostrowski SR, Jauffred S, Febbraio M, Pedersen BK. Exercise and IL‐6 infusion inhibit endotoxin‐induced TNF‐α production in humans. FASEB J. 2003;17(8).
Zheng G, Qiu P, Xia R, Lin H, Ye B, Tao J, et al. Effect of aerobic exercise on inflammatory markers in healthy middle-aged and older adults: A systematic review and meta-analysis of randomized controlled trials. Vol. 11, Frontiers in Aging Neuroscience. 2019.
Rose GL, Mielke GI, Durr M, Schaumberg MA. Effect of resistance training on chronic inflammation: A systematic review and meta-analysis. Vol. 4, Translational Sports Medicine. 2021.
Despeghel M, Reichel T, Zander J, Krüger K, Weyh C. Effects of a 6 week low‐dose combined resistance and endurance training on t cells and systemic inflammation in the elderly. Cells. 2021;10(4).
Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al. A Meta-Analysis of Cytokines in Major Depression. Biol Psychiatry. 2010;67(5).
Goldsmith DR, Rapaport MH, Miller BJ. A meta-analysis of blood cytokine network alterations in psychiatric patients: Comparisons between schizophrenia, bipolar disorder and depression. In: Molecular Psychiatry. 2016.
Oddy WH, Allen KL, Trapp GSA, Ambrosini GL, Black LJ, Huang RC, et al. Dietary patterns, body mass index and inflammation: Pathways to depression and mental health problems in adolescents. Brain Behav Immun. 2018;69.
Parletta N, Zarnowiecki D, Cho J, Wilson A, Bogomolova S, Villani A, et al. A Mediterranean-style dietary intervention supplemented with fish oil improves diet quality and mental health in people with depression: A randomized controlled trial (HELFIMED). Nutr Neurosci. 2019;22(7).
Li X, Chen M, Yao Z, Zhang T, Li Z. Dietary inflammatory potential and the incidence of depression and anxiety: a meta-analysis. Vol. 41, Journal of Health, Population and Nutrition. 2022.
Ostan R, Lanzarini C, Pini E, Scurti M, Vianello D, Bertarelli C, et al. Inflammaging and Cancer: A challenge for the mediterranean diet. Vol. 7, Nutrients. 2015.
Platania A, Zappala G, Mirabella MU, Gullo C, Mellini G, Beneventano G, et al. Association between Mediterranean diet adherence and dyslipidaemia in a cohort of adults living in the Mediterranean area. Int J Food Sci Nutr. 2018;69(5).
Mertens E, Mullie P, Deforche B, Lefevre J, Charlier R, Huybrechts I, et al. Cross-sectional study on the relationship between the Mediterranean Diet Score and blood lipids. Nutr J. 2014;13(1).
Magriplis E, Panagiotakos D, Mitsopoulou AV, Karageorgou D, Bakogianni I, Dimakopoulos I, et al. Prevalence of hyperlipidaemia in adults and its relation to the Mediterranean diet: the Hellenic National Nutrition and Health Survey (HNNHS). Eur J Prev Cardiol. 2019;26(18).
Giannini C, Diesse L, D’Adamo E, Chiavaroli V, de Giorgis T, Di Iorio C, et al. Influence of the Mediterranean diet on carotid intima-media thickness in hypercholesterolaemic children: A 12-month intervention study. Nutr Metab Cardiovasc Dis. 2014;24(1).
Vitale M, Masulli M, Calabrese I, Rivellese AA, Bonora E, Signorini S, et al. Impact of a mediterranean dietary pattern and its components on cardiovascular risk factors, glucose control, and body weight in people with type 2 diabetes: A real-life study. Nutrients. 2018;10(8).
Neufcourt L, Assmann KE, Fezeu LK, Touvier M, Graffouillère L, Shivappa N, et al. Prospective association between the dietary inflammatory index and metabolic syndrome: Findings from the SU.VI.MAX study. Nutr Metab Cardiovasc Dis. 2015;25(11).
Briguglio M, Vitale JA, Galentino R, Banfi G, Dina CZ, Bona A, et al. Healthy eating, physical activity, and sleep hygiene (HEPAS) as the winning triad for sustaining physical and mental health in patients at risk for or with neuropsychiatric disorders: Considerations for clinical practice. Neuropsychiatr Dis Treat. 2020;16.
Huffman JC, Celano CM, Beach SR, Motiwala SR, Januzzi JL. Depression and cardiac disease: Epidemiology, mechanisms, and diagnosis. Vol. 2013, Cardiovascular Psychiatry and Neurology. 2013.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Kacper Pleska, Joanna Wojtania, Michał Łepik, Zofia Uszok, Krzysztof Rosiak, Kacper Reguła, Kamil Waloch, Szymon Piaszczyński, Andrzej Czajka, Bartłomiej Szymański
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 176
Number of citations: 0
